DFCM
CLDI icon

Dark Forest Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Dark Forest Capital Management’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17
Closed -$20.5K – 1088
2023
Q1 		$20.5K Hold
17
– – ﹤0.01% 961
2022
Q4 		$20.3K Hold
17
– – 0.01% 577
2022
Q3 		$20K Hold
17
– – ﹤0.01% 626
2022
Q2 		$20K Hold
17
– – ﹤0.01% 472
2022
Q1 		$19K Buy
17
+6
+55% +$7.09K ﹤0.01% 798
2021
Q4 		$13K Buy
+11
New +$13K ﹤0.01% 825

Other funds holding CLDI

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return

Dark Forest Capital Management's CLDI Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Calidi Biotherapeutics (CLDI) in Q2 2023, closing a stake of 17 shares — an estimated $20.5K sold.

Dark Forest Capital Management first reported a position in CLDI in Q4 2021 and held it in 6 quarters. The position peaked at $20.5K in Q1 2023. 24 funds tracked by Wall St. Rank hold CLDI as of Q2 2023.

  • Dark Forest Capital Management reported no remaining Calidi Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 17 Calidi Biotherapeutics shares in Q2 2023, an estimated $20.5K.
  • Dark Forest Capital Management first reported a position in Calidi Biotherapeutics in Q4 2021 and held it in 6 quarters.
  • Dark Forest Capital Management's Calidi Biotherapeutics position peaked at $20.5K in Q1 2023.
  • 24 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.